Peptest News & Industry Updates

Cytosponge helps to identify more Barrett’s oesophagus

Cytosponge helps to identify more Barrett’s oesophagus

Trials of a non-endoscopic diagnostic tool that collects oesophageal cells has boosted the detection of Barrett's oesophagus (BO) in patients with long-term reflux symptoms. How the Cytosponge works The Cytosponge consists of a small pill attached to a thread. When...

read more
Reflux drugs linked with Covid-19 symptoms

Reflux drugs linked with Covid-19 symptoms

Researchers are investigating whether medication used to treat people with reflux disease could also help people with the coronavirus. While other studies suggest reflux drugs may double the risk of diagnosing positive for Covid-19.

read more
Pregnancy symptoms and reflux

Pregnancy symptoms and reflux

Reflux symptoms, such as heartburn, indigestion and the need to burp, are common during pregnancy – especially during the second and third trimesters.

read more
Peptest labs to reopen for reflux testing

Peptest labs to reopen for reflux testing

We’re delighted to announce that the Peptest laboratories will reopen for testing of saliva samples for pepsin on Monday 25 May. During the coronavirus pandemic we made the decision to temporarily suspend testing due to restrictions on staff movements and concerns...

read more